Pharmacovigilance insights into drug-induced cystitis: analysis of FDA data from 2004 to 2024

Background Drug-induced cystitis (DIC) significantly impacts patient quality of life and treatment outcomes. This study investigates the incidence and characteristics of DIC using data from the FDA Adverse Event Reporting System (FAERS).